{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:02:28Z","timestamp":1784786548196,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["LTGY23H070001"],"award-info":[{"award-number":["LTGY23H070001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Projects of Jinhua Science and Technology Bureau","award":["2024-3-042"],"award-info":[{"award-number":["2024-3-042"]}]},{"name":"Key Projects of Jinhua Science and Technology Bureau","award":["2022-3-137"],"award-info":[{"award-number":["2022-3-137"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05969-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:06:30Z","timestamp":1779332790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AdipoRon ameliorates vascular endothelial injury in type 2 diabetes mellitus and is associated with suppression of the NLRP3-Caspase-1-GSDMD pyroptosis axis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"Suppl 1","key":"5969_CR1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"A American Diabetes","year":"2021","unstructured":"American Diabetes A. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15\u201333.","journal-title":"Diabetes Care"},{"issue":"1","key":"5969_CR2","doi-asserted-by":"publisher","first-page":"2402260","DOI":"10.1080\/10641963.2024.2402260","volume":"46","author":"L Yang","year":"2024","unstructured":"Yang L, Zhu X, Zhu J, Hu Z, Wang C, Luo H, Bai X. Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring. Clin Exp Hypertens. 2024;46(1):2402260.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"5969_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3\u201316.","journal-title":"Diabetologia"},{"issue":"1","key":"5969_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","volume":"65","author":"MK Ali","year":"2022","unstructured":"Ali MK, Pearson-Stuttard J, Selvin E, Gregg EW. Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2022;65(1):3\u201313.","journal-title":"Diabetologia"},{"issue":"1","key":"5969_CR5","doi-asserted-by":"publisher","first-page":"2373467","DOI":"10.1080\/10641963.2024.2373467","volume":"46","author":"X Liu","year":"2024","unstructured":"Liu X, Su Y, Liu J, Liu D, Yu C. Inhibition of Th17 cell differentiation by aerobic exercise improves vasodilatation in diabetic mice. Clin Exp Hypertens. 2024;46(1):2373467.","journal-title":"Clin Exp Hypertens"},{"key":"5969_CR6","doi-asserted-by":"crossref","unstructured":"Sanabria-de la Torre R, Garcia-Fontana C, Gonzalez-Salvatierra S, Andujar-Vera F, Martinez-Heredia L, Garcia-Fontana B, Munoz-Torres M. The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus. Int J Mol Sci. 2022;23(13):6995.","DOI":"10.3390\/ijms23136995"},{"issue":"7","key":"5969_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41565-022-01125-0","volume":"17","author":"B Chen","year":"2022","unstructured":"Chen B, Yan Y, Yang Y, Cao G, Wang X, Wang Y, Wan F, Yin Q, Wang Z, Li Y, et al. A pyroptosis nanotuner for cancer therapy. Nat Nanotechnol. 2022;17(7):788\u201398.","journal-title":"Nat Nanotechnol"},{"key":"5969_CR8","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2147\/JIR.S291453","volume":"14","author":"AA Mamun","year":"2021","unstructured":"Mamun AA, Wu Y, Nasrin F, Akter A, Taniya MA, Munir F, Jia C, Xiao J. Role of Pyroptosis in Diabetes and Its Therapeutic Implications. J Inflamm Res. 2021;14:2187\u2013206.","journal-title":"J Inflamm Res"},{"key":"5969_CR9","doi-asserted-by":"publisher","first-page":"7812407","DOI":"10.1155\/2022\/7812407","volume":"2022","author":"M Luo","year":"2022","unstructured":"Luo M, Hu Y, Lv D, Xie L, Yang S, Zuo D, Xue Y, He A. Recurrent Hypoglycemia Impaired Vascular Function in Advanced T2DM Rats by Inducing Pyroptosis. Oxid Med Cell Longev. 2022;2022:7812407.","journal-title":"Oxid Med Cell Longev"},{"key":"5969_CR10","doi-asserted-by":"crossref","unstructured":"Khoramipour K, Chamari K, Hekmatikar AA, Ziyaiyan A, Taherkhani S, Elguindy NM, Bragazzi NL. Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients. 2021;13(4):1180.","DOI":"10.3390\/nu13041180"},{"key":"5969_CR11","doi-asserted-by":"crossref","unstructured":"Guo Q, Cao S, Wang X. Adiponectin Intervention to Regulate Betatrophin Expression, Attenuate Insulin Resistance and Enhance Glucose Metabolism in Mice and Its Response to Exercise. Int J Mol Sci. 2022;23(18):10630.","DOI":"10.3390\/ijms231810630"},{"issue":"6","key":"5969_CR12","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/db23-0455","volume":"73","author":"S Fawaz","year":"2024","unstructured":"Fawaz S, Martin Alonso A, Qiu Y, Ramnath R, Stowell-Connolly H, Gamez M, May C, Down C, Coward RJ, Butler MJ, et al. Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes. Diabetes. 2024;73(6):964\u201376.","journal-title":"Diabetes"},{"key":"5969_CR13","doi-asserted-by":"publisher","first-page":"103806","DOI":"10.1016\/j.etap.2021.103806","volume":"90","author":"MM Samaha","year":"2022","unstructured":"Samaha MM, Helal MG, El-Sherbiny M, Said E, Salem HA. Diacerein versus adipoRon as adiponectin modulators in experimentally-induced end-stage type 2 diabetes mellitus in rats. Environ Toxicol Pharmacol. 2022;90:103806.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"5969_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00210-024-03362-7","volume":"398","author":"LF Laurindo","year":"2025","unstructured":"Laurindo LF, Laurindo LF, Rodrigues VD, Catharin V, Simili OAG, Barboza GO, Catharin VCS, Sloan KP, Barbalho SM. Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention-a systematic review. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(1):165\u201377.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5969_CR15","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10397","key":"5969_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBDD Collaborators","year":"2023","unstructured":"Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"},{"issue":"5","key":"5969_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/nutrit\/nuae165","volume":"83","author":"D Sivri","year":"2025","unstructured":"Sivri D, Akdevelioglu Y. Effect of Fatty Acids on Glucose Metabolism and Type 2 Diabetes. Nutr Rev. 2025;83(5):897\u2013907.","journal-title":"Nutr Rev"},{"issue":"2","key":"5969_CR18","doi-asserted-by":"publisher","first-page":"e3733","DOI":"10.1002\/dmrr.3733","volume":"40","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang J, Tao SY, Liang Z, Xie R, Liu NN, Deng R, Zhang Y, Deng D, Jiang G. Mitochondrial damage-associated molecular patterns: A new insight into metabolic inflammation in type 2 diabetes mellitus. Diabetes Metab Res Rev. 2024;40(2):e3733.","journal-title":"Diabetes Metab Res Rev"},{"key":"5969_CR19","doi-asserted-by":"crossref","unstructured":"Wen Y, Ma X, Mei S, Wuyun Q, Yan J. Emerging Insights into the Relationship Between Amino Acid Metabolism and Diabetic Cardiomyopathy. Biomolecules. 2025;15(7):916.","DOI":"10.3390\/biom15070916"},{"key":"5969_CR20","doi-asserted-by":"publisher","first-page":"1348410","DOI":"10.3389\/fphar.2024.1348410","volume":"15","author":"Y Pan","year":"2024","unstructured":"Pan Y, Li J, Lin P, Wan L, Qu Y, Cao L, Wang L. A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer\u2019s disease, and their co-morbidities. Front Pharmacol. 2024;15:1348410.","journal-title":"Front Pharmacol"},{"key":"5969_CR21","doi-asserted-by":"crossref","unstructured":"Karamitsos K, Oikonomou E, Theofilis P, Ikonomidis I, Kassi E, Lambadiari V, Gialafos E, Tsatsaragkou A, Mystakidi VC, Zisimos K, et al. The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications. J Clin Med. 2025;14(13):4606.","DOI":"10.3390\/jcm14134606"},{"issue":"1","key":"5969_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-024-06306-1","volume":"68","author":"DT Meier","year":"2025","unstructured":"Meier DT, de Paula Souza J, Donath MY. Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity. Diabetologia. 2025;68(1):3\u201316.","journal-title":"Diabetologia"},{"key":"5969_CR23","doi-asserted-by":"publisher","first-page":"753660","DOI":"10.3389\/fcell.2021.753660","volume":"9","author":"J Xu","year":"2021","unstructured":"Xu J, Cai S, Zhao J, Xu K, Ji H, Wu C, Xiao J, Wu Y. Advances in the Relationship Between Pyroptosis and Diabetic Neuropathy. Front Cell Dev Biol. 2021;9:753660.","journal-title":"Front Cell Dev Biol"},{"key":"5969_CR24","doi-asserted-by":"publisher","first-page":"791848","DOI":"10.3389\/fphys.2021.791848","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Lu Y, Meng J, Wang Z. Pyroptosis and Its Regulation in Diabetic Cardiomyopathy. Front Physiol. 2021;12:791848.","journal-title":"Front Physiol"},{"key":"5969_CR25","doi-asserted-by":"publisher","first-page":"824165","DOI":"10.3389\/fcell.2022.824165","volume":"10","author":"D Song","year":"2022","unstructured":"Song D, Li M, Yu X, Wang Y, Fan J, Yang W, Yang L, Li H. The Molecular Pathways of Pyroptosis in Atherosclerosis. Front Cell Dev Biol. 2022;10:824165.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5969_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13098-023-01216-5","volume":"15","author":"T Li","year":"2023","unstructured":"Li T, Yang J, Tan A, Chen H. Irisin suppresses pancreatic beta cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX\/TXNIP signaling axis. Diabetol Metab Syndr. 2023;15(1):239.","journal-title":"Diabetol Metab Syndr"},{"key":"5969_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2019.11.007","volume":"62","author":"S Christgen","year":"2020","unstructured":"Christgen S, Kanneganti TD. Inflammasomes and the fine line between defense and disease. Curr Opin Immunol. 2020;62:39\u201344.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"5969_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","volume":"26","author":"D Frank","year":"2019","unstructured":"Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99\u2013114.","journal-title":"Cell Death Differ"},{"issue":"1","key":"5969_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-022-00906-9","volume":"8","author":"F Yao","year":"2022","unstructured":"Yao F, Jin Z, Zheng Z, Lv X, Ren L, Yang J, Chen D, Wang B, Yang W, Chen L, et al. HDAC11 promotes both NLRP3\/caspase-1\/GSDMD and caspase-3\/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells. Cell Death Discov. 2022;8(1):112.","journal-title":"Cell Death Discov"},{"issue":"8","key":"5969_CR30","doi-asserted-by":"publisher","first-page":"e23444","DOI":"10.1002\/jbt.23444","volume":"37","author":"M Chen","year":"2023","unstructured":"Chen M, Hu C, Yang L, Guo Q, Liang Y, Wang W. Saikosaponin-D induces the pyroptosis of lung cancer by increasing ROS and activating the NF-kappaB\/NLRP3\/caspase-1\/GSDMD pathway. J Biochem Mol Toxicol. 2023;37(8):e23444.","journal-title":"J Biochem Mol Toxicol"},{"key":"5969_CR31","doi-asserted-by":"publisher","first-page":"115042","DOI":"10.1016\/j.bcp.2022.115042","volume":"200","author":"C Wang","year":"2022","unstructured":"Wang C, Wang L, Huang C, Liu Y, Liu J, Kuang H, Pang Q, Han H, Fan R. Involvement of NLRP3\/Caspase-1\/GSDMD-Dependent pyroptosis in BPA-Induced apoptosis of human neuroblastoma cells. Biochem Pharmacol. 2022;200:115042.","journal-title":"Biochem Pharmacol"},{"key":"5969_CR32","doi-asserted-by":"publisher","first-page":"117931","DOI":"10.1016\/j.jep.2024.117931","volume":"327","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang S, Zhang Y, Wang H, Chen Y, Lu H. Activation of NRF2 by epiberberine improves oxidative stress and insulin resistance in T2DM mice and IR-HepG2 cells in an AMPK dependent manner. J Ethnopharmacol. 2024;327:117931.","journal-title":"J Ethnopharmacol"},{"key":"5969_CR33","doi-asserted-by":"publisher","first-page":"121656","DOI":"10.1016\/j.lfs.2023.121656","volume":"322","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang K, Hou L, Liao J, Zhang H, Han Q, Guo J, Li Y, Hu L, Pan J, et al. Endoplasmic reticulum stress contributes to pyroptosis through NF-kappaB\/NLRP3 pathway in diabetic nephropathy. Life Sci. 2023;322:121656.","journal-title":"Life Sci"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05969-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:18:10Z","timestamp":1784783890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5969"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05969-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approvals were granted by the Experimental Animal Ethics Committee of Jinhua Food and Drug Inspection and Testing Research Institute (approval no. AL-JSYJ202416).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"633"}}